AngioDynamics, Inc. ANGO
15.49
0.21
1.37%
as of 25 Sep
- Market cap
- $631.6M
- P/E
- 0.0×
Follow ANGO
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(17.10%) | (15.26%) | (17.47%) | (20.77%) | |
| (11.48%) | (9.87%) | (11.50%) | (13.43%) | ||
ROIC |
(16.74%) | (15.10%) | (16.38%) | (21.34%) | |
Return on Tangible Assets |
(26.87%) | (23.11%) | (26.46%) | (31.74%) | |
Average Days of Receivables |
51.76 | 52.78 | 53.00 | 55.09 | |
Free Cash Flow per Share |
(0.29) | (0.22) | 0.04 | 0.01 | |
Free Cash Flow |
(11.89) | (9.33) | 1.50 | 0.51 | |
Capital Expenditures |
(4.10) | (3.73) | (2.94) | (2.58) | |
Piotroski F-Score |
5.00 | 5.00 | 6.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(3.58%) | (2.57%) | 2.11% | 1.37% | |
Accounts Receivable Turnover |
7.32 | 7.02 | 6.64 | 7.02 | |
Accounts Payable Turnover |
4.37 | 3.98 | 4.83 | 4.48 | |
Inventory Turnover |
2.17 | 2.12 | 2.36 | 2.54 | |
Average Days of Payables |
84.40 | 92.54 | 74.09 | 79.17 | |
Days of Inventory on Hand |
164.80 | 171.45 | 149.11 | 131.74 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.01 | |
Research and Development Expense of Revenue |
8.76% | 9.01% | 8.88% | 9.20% | |
Selling, General and Administrative Expense of Revenue |
49.66% | 48.88% | 48.57% | 49.06% | |
Share Based Compensation of Revenue |
3.67% | 3.71% | 3.72% | 4.36% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.24 | 0.20 | (0.14) | (0.08) | |
Depreciation/Fixed assets |
0.81 | 0.78 | 0.80 | 0.85 | |
Capex/Depreciation |
(0.16) | (0.16) | (0.13) | (0.11) | |
Revenue per Share |
7.30 | 7.40 | 7.54 | 7.71 | |
Operating CF per Share |
(0.19) | (0.13) | 0.11 | 0.07 | |
Capex per Share |
(0.10) | (0.09) | (0.07) | (0.06) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(10.67%) | (9.02%) | (10.00%) | (11.48%) |
Columns are period end dates